Targeting PD-1/PD-L1 in lung cancer: current perspectives

Increased understanding of tumor immunology has led to the development of effective immunotherapy treatments. One of the most important advances in this field has been due to pharmacological design of antibodies against immune checkpoint inhibitors. Anti-PD-1/PD-L1 antibodies are currently in advanc...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Lung Cancer (Auckl)
Päätekijät: González-Cao, María, Karachaliou, Niki, Viteri, Santiago, Morales-Espinosa, Daniela, Teixidó, Cristina, Sánchez Ruiz, Jesús, Molina-Vila, Miquel Ángel, Santarpia, Mariacarmela, Rosell, Rafael
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove Medical Press 2015
Aiheet:
Review
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5217517/
https://ncbi.nlm.nih.gov/pubmed/28210151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S55176
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia